Alexander's(ALX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALX Alexander's

Market Closed 02-06 16:00:00 EST

255.07

-0.64

-0.25%

盘后255.07

+0.000.00%

16:10 EST

High259.23	Low250.17	Vol96.39K
Open257.79	D1 Closing255.71	Amplitude3.54%
Mkt Cap1.30B	Tradable Cap542.19M	Total Shares5.11M
T/O24.68M	T/O Rate4.53%	Tradable Shares2.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALX","market":"US","secType":"STK","nameCN":"Alexander's","latestPrice":255.07,"timestamp":1770411600000,"preClose":255.71,"halted":0,"volume":96388,"hourTrading":{"tag":"盘后","latestPrice":255.07,"preClose":255.07,"latestTime":"16:10 EST","volume":114,"amount":29093.7,"timestamp":1770412204689,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002502835243048824,"floatShares":2125671,"shares":5107290,"eps":7.139782,"marketStatus":"Market Closed","change":-0.64,"latestTime":"02-06 16:00:00 EST","open":257.79,"high":259.23,"low":250.1731,"amount":24678224.0742,"amplitude":0.035419,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.139782,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-7416000000,"exchange":"NYSE","adjPreClose":255.71,"dividendRate":0.070577,"preHourTrading":{"tag":"盘前","latestPrice":255.71,"preClose":255.71,"latestTime":"08:03 EST","volume":2,"amount":511.42,"timestamp":1770382988989,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":255.07,"preClose":255.07,"latestTime":"16:10 EST","volume":114,"amount":29093.7,"timestamp":1770412204689,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9684627660997228},"requestUrl":"/m/hq/s/ALX/tweets","defaultTab":"tweets","newsList":[{"id":"1154646165","title":"Earning Preview: Alexander's Q4 revenue is expected to decrease by 3.26%, and institutional views are limited and cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1154646165","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1154646165?lang=en_us&edition=fundamental","pubTime":"2026-02-02 11:07","pubTimestamp":1770001626,"startTime":"0","endTime":"0","summary":"Abstract Alexander's will report Q4 2025 results on February 09, 2026 Pre-Market, with investors watching revenue resilience, margins, and rent collections amid stable occupancy and muted leasing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Alexander's Q4 revenue is expected to decrease by 3.26%, and institutional views are limited and cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX"],"gpt_icon":0},{"id":"2609302417","title":"ALX Oncology Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2609302417","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609302417?lang=en_us&edition=fundamental","pubTime":"2026-02-05 23:56","pubTimestamp":1770306960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALXO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2026 10:56 ET (15:56 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX"],"gpt_icon":0},{"id":"2609927353","title":"Alexander's Keeps Quarterly Dividend at $4.50 a Share, Payable Feb. 27 to Shareholders of Record on Feb. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2609927353","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609927353?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:46","pubTimestamp":1770230814,"startTime":"0","endTime":"0","summary":"Price: 256.28, Change: +5.74, Percent Change: +2.29","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALX"],"gpt_icon":0},{"id":"2609657392","title":"Alexander's Inc. zahlt Quartalsdividende von 4,50 US-Dollar je Aktie","url":"https://stock-news.laohu8.com/highlight/detail?id=2609657392","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609657392?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:38","pubTimestamp":1770230299,"startTime":"0","endTime":"0","summary":"Alexander’s Inc. hat eine vierteljhrliche Dividende von 4,50 US-Dollar je Aktie beschlossen, zahlbar am 27. Februar 2026 an die Aktionre mit Stand vom 17. Februar 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alexander's Inc. published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL57V0TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","LU2210149790.SGD","ALX","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4080","NDAQ","BK4231","BK4112"],"gpt_icon":0},{"id":"2609392652","title":"Alexander's Inc. Declares $4.50 Quarterly Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2609392652","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609392652?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:38","pubTimestamp":1770230299,"startTime":"0","endTime":"0","summary":"Alexander's Inc. has declared a regular quarterly dividend of $4.50 per share, payable on February 27, 2026, to stockholders of record as of February 17, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alexander's Inc. published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL7TCHJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","BK4194","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","VNO","BK4080","BK4231","LU2210150020.SGD","NDAQ","SG9999014039.USD","LU2210149790.SGD","BK4223","LU2095319765.USD","BK4112","BK4585","BK4588","SG9999014021.USD","SG9999014005.SGD","SG9999014013.SGD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2608316878","title":"What Atlas Arteria (ASX:ALX)'s Q4 Toll Revenue Growth Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2608316878","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608316878?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:15","pubTimestamp":1769984110,"startTime":"0","endTime":"0","summary":"Atlas Arteria recently reported that Q4 and full-year 2025 proportionate toll revenues rose around 9.5%, supported by toll increases, steady traffic and favourable currency movements across its European and US toll road portfolio.\nThe strongest contributions came from French assets such as the A79 and ADELAC and US roads including Dulles Greenway and Chicago Skyway, where higher usage and improving cross-border activity highlighted the resilience of the network.\nWith this revenue growth...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3252000-choice2-main-header/1585187464700","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3252000-choice2-main-header/1585187464700"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/transportation/asx-alx/atlas-arteria-shares/news/what-atlas-arteria-asxalxs-q4-toll-revenue-growth-means-for","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/transportation/asx-alx/atlas-arteria-shares/news/what-atlas-arteria-asxalxs-q4-toll-revenue-growth-means-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALX","ALX.AU"],"gpt_icon":0},{"id":"2607604605","title":"ALX Oncology announces major underwritten public equity offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2607604605","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607604605?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:58","pubTimestamp":1769781528,"startTime":"0","endTime":"0","summary":"The latest announcement is out from ALX Oncology Holdings ( ($ALXO) ). On January 30, 2026, ALX Oncology priced an underwritten public offering of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alx-oncology-announces-major-underwritten-public-equity-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alx-oncology-announces-major-underwritten-public-equity-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALX","BK4080","BK4231"],"gpt_icon":0},{"id":"2607045042","title":"ALX Oncology Announces Pricing of Underwritten Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2607045042","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607045042?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:30","pubTimestamp":1769779800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan.  30, 2026  (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/30/3229530/0/en/ALX-Oncology-Announces-Pricing-of-Underwritten-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","ALX","BK4231"],"gpt_icon":0},{"id":"2607453560","title":"New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2607453560","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607453560?lang=en_us&edition=fundamental","pubTime":"2026-01-30 21:15","pubTimestamp":1769778900,"startTime":"0","endTime":"0","summary":"- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer – - Full","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/30/3229503/0/en/New-Data-Demonstrate-CD47-Expression-Level-Helps-Predict-Response-to-ALX-Oncology-s-Evorpacept-in-Combination-with-Ziihera-zanidatamab-hrii-in-Advanced-HER2-Positive-Breast-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","ALX","BK4157","BK4231","AEIS","LU0757428866.USD","IE0031619046.USD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4080"],"gpt_icon":0},{"id":"2605435063","title":"ALX Oncology Expands Inducement Equity Plan for Hiring","url":"https://stock-news.laohu8.com/highlight/detail?id=2605435063","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605435063?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:57","pubTimestamp":1769032625,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings ( ($ALXO) ) has shared an update. Effective January 21, 2026, ALX Oncology Holdings Inc.’s board amended its 2025 Inducement ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alx-oncology-expands-inducement-equity-plan-for-hiring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alx-oncology-expands-inducement-equity-plan-for-hiring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4080","BK4585","EQR","BK4588","ALX","BK4231"],"gpt_icon":0},{"id":"2605864784","title":"Alexander's Inc. Publishes Update to Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2605864784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605864784?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:42","pubTimestamp":1769010154,"startTime":"0","endTime":"0","summary":"Alexander’s Inc. will release its fourth quarter and full year 2025 earnings results on Monday, February 9, 2026, before the New York Stock Exchange opens. Results will be available through the company's annual report on Form 10-K filed with the U.S. Securities and Exchange Commission. Vornado Realty Trust, which manages Alexander’s operations, will host its quarterly earnings conference call and audio webcast on Tuesday, February 10, 2026, at 10:00 a.m. Eastern Time. Information concerning Alexander’s may be discussed on the call. The live webcast can be accessed in the Investor Relations section of Vornado's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alexander's Inc. published the original content used to generate this n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL3C4mfT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014005.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","IE00BGHQF748.EUR","VNO","ALX","BK4231","IE00BKPKM429.USD","BK4080","IE00B3QW5Z07.USD","BK4588","NDAQ","BK4194","BK4223","BK4112","SG9999014021.USD","LU2210149790.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"2601765367","title":"ALX Oncology first patient dosed in Phase 2 ASPEN-09-Breast trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601765367","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601765367?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:55","pubTimestamp":1767880550,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced that the first patient has been dosed in the Company’s Phase 2 ASPEN-09-Breast trial evaluating its investigational C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-first-patient-dosed-in-phase-2-aspen-09-breast-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-first-patient-dosed-in-phase-2-aspen-09-breast-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4139","ALX","ALXO","BK4231"],"gpt_icon":0},{"id":"2601236783","title":"ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2601236783","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601236783?lang=en_us&edition=fundamental","pubTime":"2026-01-08 21:30","pubTimestamp":1767879000,"startTime":"0","endTime":"0","summary":"- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of chemotherapy in HER2-positive metastatic breast cancer; interim a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215379/0/en/ALX-Oncology-Advances-Separate-Clinical-Trials-Evaluating-Investigational-CD47-Inhibitor-Evorpacept-and-Novel-EGFR-Targeted-Antibody-Drug-Conjugate-ALX2004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4231","BK4080","BK4195","BK4213","BK4211","CRC","LU0266512127.USD","LU0456854461.SGD","ORR","ADC","OS","BK4097","ALX"],"gpt_icon":0},{"id":"2595728733","title":"Alexander’s Completes Restructuring of Retail Loan at 731 Lexington Avenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2595728733","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595728733?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:44","pubTimestamp":1767015840,"startTime":"0","endTime":"0","summary":"PARAMUS, N.J., Dec.  29, 2025  (GLOBE NEWSWIRE) -- Alexander’s, Inc. (NYSE: ALX) today announced that it has restructured the $300 million mortgage loan on the retail condominium of 731 Lexington Aven","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/29/3210929/0/en/Alexander-s-Completes-Restructuring-of-Retail-Loan-at-731-Lexington-Avenue.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","BK4080","BK4231"],"gpt_icon":0},{"id":"2590532821","title":"Alexander’s (ALX) Valuation After Rego Park II Refinancing and New $175 Million Interest-Only Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2590532821","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590532821?lang=en_us&edition=fundamental","pubTime":"2025-12-11 02:16","pubTimestamp":1765390618,"startTime":"0","endTime":"0","summary":"Alexander's (ALX) just reshaped its balance sheet by refinancing the Rego Park II shopping center with a $175 million interest only loan maturing in 2030, while trimming its prior debt load.\nSee our latest analysis for Alexander's.\nAgainst that backdrop, Alexander's 10.1% year to date share price return and 9.7% one year total shareholder return suggest steady but not explosive momentum, with the recent refinancing potentially easing some balance sheet risk concerns.\nIf you are weighing how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-alx/alexanders/news/alexanders-alx-valuation-after-rego-park-ii-refinancing-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-alx/alexanders/news/alexanders-alx-valuation-after-rego-park-ii-refinancing-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALX","DCF","BK7090","BK4080","BK4231","ALX.AU"],"gpt_icon":0},{"id":"2590341096","title":"Alexander’s Completes $175 Million Refinancing of Rego Park Ii","url":"https://stock-news.laohu8.com/highlight/detail?id=2590341096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590341096?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:59","pubTimestamp":1765288741,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUAB9MGKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALX","BK4231","BK4080"],"gpt_icon":0},{"id":"2590349058","title":"Alexander's Inc. Secures $175 Million Refinancing for Rego Park II Shopping Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349058","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349058?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:27","pubTimestamp":1765286872,"startTime":"0","endTime":"0","summary":"Alexander's Inc. has completed a $175 million refinancing of its 615,000 square foot Rego Park II shopping center in Queens, New York. The new interest-only loan carries a rate of SOFR plus 2.00%, currently 5.82%, and matures in December 2030. As part of the refinancing, Alexander's paid down $23.5 million from the previous $198.5 million loan, which had an interest rate of SOFR plus 1.45% and was set to mature in December 2025. Alexander's Inc. is a real estate investment trust with five properties in New York City.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alexander's Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDLbbvKyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","ALX"],"gpt_icon":0},{"id":"2589877324","title":"ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589877324","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589877324?lang=en_us&edition=fundamental","pubTime":"2025-12-07 21:00","pubTimestamp":1765112400,"startTime":"0","endTime":"0","summary":"- Combination of evorpacept plus rituximab and lenalidomide (R2) generated complete responses (CR) in 92% of patients with untreated indolent non-Hodgkin lymphoma (iNHL) comparing favorably to an appr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/07/3201128/0/en/ALX-Oncology-Announces-Positive-Results-from-Ongoing-Investigator-Sponsored-Phase-2-Trial-Evaluating-Evorpacept-in-Combination-with-Standard-of-Care-Treatment-in-Patients-with-Indo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMP","ASH","ALX","PFS","BK4097","BK4124","LU2463526074.USD","OS","BK4195","ORR","BK4161","BK4211","BK4213","BK4109","BK4231","BK4080","PR","CR"],"gpt_icon":0},{"id":"2588725758","title":"Henderson Land Development Files Directors List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2588725758","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588725758?lang=en_us&edition=fundamental","pubTime":"2025-12-01 18:04","pubTimestamp":1764583491,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Henderson Land Development Company Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL39Kxn9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4223","VNO","BK4585","BK4588","ALX","BK4080","BK1601","BK1240","00012","BK1559","BK4194"],"gpt_icon":0},{"id":"2587791380","title":"PT International Development Corporation Files Directors List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2587791380","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587791380?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:10","pubTimestamp":1764497433,"startTime":"0","endTime":"0","summary":"PT International Development Corporation Limited has announced an updated list of directors and their respective roles and committee memberships, as filed with the Hong Kong Exchanges and Clearing Limited. The Board comprises Mr. Ching Man Chun, Louis  and Mr. Wong Kung Ho, Alexander as Executive Directors; Ms. Wong Man Ming, Melinda as Non-executive Director; and Mr. Yam Kwong Chun, Mr. Wong Yee Shuen, Wilson, and Mr. Lam Yik Tung as Independent Non-executive Directors. In terms of committee memberships, Mr. Wong Yee Shuen, Wilson serves as Chairman of the Audit Committee, and Mr. Lam Yik Tung chairs the Remuneration Committee. Mr. Yam Kwong Chun is Chairman of the Nomination Committee, while Mr. Ching Man Chun, Louis chairs the Corporate Governance Committee. Other committee members include Ms. Wong Man Ming, Melinda , with Mr. Yam Kwong Chun, Mr. Wong Yee Shuen, Wilson, and Mr. Lam Yik Tung also serving as members across the various committees.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251130:nNDL8HqWJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00372","BK4080","BK1124","BK4585","BK4223","BK4194","BK4588","VNO","ALX","BK4231"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alx-inc.com","stockEarnings":[{"period":"1week","weight":0.0415},{"period":"1month","weight":0.1446},{"period":"3month","weight":0.1006},{"period":"6month","weight":0.1449},{"period":"1year","weight":0.2983},{"period":"ytd","weight":0.1704}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alexander's, Inc. (NYSE: ALX) is a real estate investment trust (REIT), incorporated in Delaware, engaged in leasing, managing, developing and redeveloping its properties. All references to we, us, our, Company and Alexander's refer to Alexander's, Inc. and its consolidated subsidiaries. We are managed by, and our properties are leased and developed by, Vornado Realty Trust (Vornado) (NYSE: VNO). We have five properties in New York City.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01062},{"month":2,"riseRate":0.478261,"avgChangeRate":0.005464},{"month":3,"riseRate":0.511111,"avgChangeRate":0.016839},{"month":4,"riseRate":0.434783,"avgChangeRate":0.00716},{"month":5,"riseRate":0.521739,"avgChangeRate":0.024688},{"month":6,"riseRate":0.5,"avgChangeRate":0.00582},{"month":7,"riseRate":0.586957,"avgChangeRate":0.014946},{"month":8,"riseRate":0.478261,"avgChangeRate":0.005583},{"month":9,"riseRate":0.5,"avgChangeRate":0.023298},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013397},{"month":11,"riseRate":0.456522,"avgChangeRate":-0.006173},{"month":12,"riseRate":0.521739,"avgChangeRate":0.017167}],"exchange":"NYSE","name":"Alexander's","nameEN":"Alexander's"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alexander's(ALX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alexander's(ALX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alexander's,ALX,Alexander's股票,Alexander's股票老虎,Alexander's股票老虎国际,Alexander's行情,Alexander's股票行情,Alexander's股价,Alexander's股市,Alexander's股票价格,Alexander's股票交易,Alexander's股票购买,Alexander's股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alexander's(ALX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alexander's(ALX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction